191 related articles for article (PubMed ID: 25869783)
1. Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data.
Kong D; Giovanello KS; Wang Y; Lin W; Lee E; Fan Y; Murali Doraiswamy P; Zhu H
J Alzheimers Dis; 2015; 46(3):695-702. PubMed ID: 25869783
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
3. Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts.
Khondoker M; Newhouse S; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Dobson R; Simmons A; ;
J Alzheimers Dis; 2015; 45(3):851-64. PubMed ID: 25649652
[TBL] [Abstract][Full Text] [Related]
4. A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease.
Barnes DE; Cenzer IS; Yaffe K; Ritchie CS; Lee SJ;
Alzheimers Dement; 2014 Nov; 10(6):646-55. PubMed ID: 24495339
[TBL] [Abstract][Full Text] [Related]
5. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
7. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
[TBL] [Abstract][Full Text] [Related]
8. Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework.
Ning K; Chen B; Sun F; Hobel Z; Zhao L; Matloff W; ; Toga AW
Neurobiol Aging; 2018 Aug; 68():151-158. PubMed ID: 29784544
[TBL] [Abstract][Full Text] [Related]
9. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
11. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
[TBL] [Abstract][Full Text] [Related]
12. Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
Moon SW; Dinov ID; Kim J; Zamanyan A; Hobel S; Thompson PM; Toga AW
J Alzheimers Dis; 2015; 48(4):1051-63. PubMed ID: 26444770
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of genetic difference between mild cognitive impairment and Alzheimer's disease through genome-wide association study].
Bai Z; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):342-346. PubMed ID: 29896728
[TBL] [Abstract][Full Text] [Related]
14. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.
Saykin AJ; Shen L; Yao X; Kim S; Nho K; Risacher SL; Ramanan VK; Foroud TM; Faber KM; Sarwar N; Munsie LM; Hu X; Soares HD; Potkin SG; Thompson PM; Kauwe JS; Kaddurah-Daouk R; Green RC; Toga AW; Weiner MW;
Alzheimers Dement; 2015 Jul; 11(7):792-814. PubMed ID: 26194313
[TBL] [Abstract][Full Text] [Related]
16. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
Hayes JP; Logue MW; Sadeh N; Spielberg JM; Verfaellie M; Hayes SM; Reagan A; Salat DH; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
Brain; 2017 Mar; 140(3):813-825. PubMed ID: 28077398
[TBL] [Abstract][Full Text] [Related]
17. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
18. Combined use of biochemical and volumetric biomarkers to assess the risk of conversion of mild cognitive impairment to Alzheimer's disease.
Nesteruk M; Nesteruk T; Styczyńska M; Mandecka M; Barczak A; Barcikowska M
Folia Neuropathol; 2016; 54(4):369-374. PubMed ID: 28139818
[TBL] [Abstract][Full Text] [Related]
19. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
20. Predicting Alzheimer's disease development: a comparison of cognitive criteria and associated neuroimaging biomarkers.
Callahan BL; Ramirez J; Berezuk C; Duchesne S; Black SE;
Alzheimers Res Ther; 2015 Nov; 7(1):68. PubMed ID: 26537709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
